info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Avian Influenza Vaccine Companies

Avian influenza, commonly known as bird flu, poses a significant threat to global poultry populations and has the potential for zoonotic transmission to humans. In response to this ongoing challenge, several pioneering companies have emerged as leaders in the development and production of avian influenza vaccines. These vaccines play a crucial role in preventing and controlling the spread of the virus among birds, safeguarding both animal welfare and human health.

Avian Influenza Vaccine Key Companies

 


Latest Avian Influenza Vaccine Companies Update:

December 2023:


The United States Department of Agriculture (USDA) announces a $10 million grant program to support research and development of advanced avian influenza vaccines for poultry. This initiative aims to create next-generation vaccines offering broader protection against diverse influenza strains.


October 2023:


Ceva Animal Health releases their CEVA FLU H5/H7 vaccine, a new recombinant adenovirus vector vaccine for poultry, providing broader coverage against various Influenza A subtypes.


July 2023:


A research team in China publishes a successful trial of a DNA vaccine for chickens, potentially paving the way for more stable and scalable vaccine production.


January 2024:


Moderna reports positive preliminary results from their Phase 1 trial for a mRNA-based avian influenza vaccine in humans. This signifies progress in creating human vaccines for potential future outbreaks.


November 2023:


The World Health Organization (WHO) updates its avian influenza preparedness plan, emphasizing the need for developing and stockpiling human vaccines alongside poultry vaccines.


August 2023:


Sanofi announces its readiness to start production of existing H5N1 vaccines if needed in an avian influenza outbreak scenario, highlighting the existing


List of Avian Influenza Vaccine Key companies in the market

  • Boehringer Ingelheim International GmbH (Germany)

  • Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China)

  • Ceva (US)

  • Yebio Bioengineering Co., Ltd (China)

  • Zoetis (US)

  • FATRO S.P.A. (Italy)

  • CAVAC (South Korea)

  • Tianjin Ringpu Bio-Technology Co., Ltd (China)

  • PT Japfa Comfeed Indonesia Tbk (Indonesia)

  • Chengdu Tech-bank Biological Products Co., Ltd (China)

  • Merck Animal Health (US)

  • Medion (Indonesia)

  • Avimex Animal Health (Mexico)

  • JOVAC (Jordan)

  • QYH BIOTECH COMPANY LIMITED (China).


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.